Genocea Biosciences, Inc. announced that John Lunger, Chief Patient Supply Officer at Adaptimmune Therapeutics plc has joined its board of directors. Mr. Lunger is Chief Patient Supply Officer at Adaptimmune. Before joining Adaptimmune, Mr. Lunger was Head of Supply Chain and Commercial Product Supply at Merrimack Pharmaceuticals.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
2023 | Genocea Biosciences, Inc. Went Out of Business | CI |
2023 | Liquidation Plan Approved for Genocea Biosciences, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 58 | |
+16.33% | 45.51B | |
-9.64% | 38.52B | |
+38.08% | 38.13B | |
+27.80% | 30.74B | |
-8.64% | 26.03B | |
+12.07% | 25.92B | |
+45.10% | 14.13B | |
+33.80% | 12.73B | |
-7.66% | 11.29B |
- Stock Market
- Equities
- GNCAQ Stock
- News Genocea Biosciences, Inc.
- John Lunger Joins Genocea Biosciences' Board of Directors